Management of fungal peritonitis : a Moroccan single peritoneal dialysis unit experience
Introduction: Fungal peritonitis (PF) in peritoneal dialysis (PD) is a serious infection that involves the functional prognosis of the peritoneum and the patient's vital prognosis. It must benefit from a fast handling but nevertheless not very codified. Each center therefore ensures an individual care of its patients.
Materiel and method: The purpose of our study is to describe our 10-year experience through our patients who presented FP. We performed a descriptive retrospective study of FP cases documented in the PD unit.
Results: the prevalence of FP was 5,1%, which represent 9 cases. Predominant clinical signs were dialysat turbidity and abdominal pain. FP was primitive for 3 patients. The antifungal therapy used was Fluconazole, which was combined with an increased number of peritoneal exchanges. DP catheter ablation was done for 8 patients with an average delay of 5.5 days. The overall outcome was favorable and 3 patients continued PD. No death or encapsulating peritonitis was a consequence of FP.
Discussion and conclusion: FP is an infectious complication in PD. Its’ death rate is elevated; dropping-out of PD rate too is elevated. The favorable evolution of our patients that stayed in PD let us think that it may be possible to maintain more patients in PD after FP.
Prasad and Gupta. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005; 25 (3):207–222.
Antoine Grillon, Pierre-Hugues Boyer et Françoise Heibel. Prélèvements à visée bactériologique des liquides de dialyse péritonéale. Comment limiter le nombre de péritonites à culture négative ? Bulletin de la Dialyse à Domicile, 2018, 1 (1):15-19. DOI: https://doi.org/10.25796/bdd.v1i1.20
Joanna Matuszkiewicz–Rowinska. Update on fungal peritonitis and its treatment. Peritoneal Dialysis International, 2009; 29 (2):S161–5.
Auricchio, S., Giovenzana, M. E., Pozzi, M., Galassi, A., Santorelli, G., Dozio, B., &Scanziani, R. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation. Clinical Kidney Journal. 2018: 11(6):874-880.
Goldie SJ et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28 (1):86–91.
Chou CY, Kao MT, Kuo HL, Liu JS, Liu YL, Huang CC. Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients. Perit Dial Int. 2006; 26 (5):607–8.
Philip Kam-Tao Li, David W. Johnson et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. September-October 2016 ; 36 (5) : 481-508.
J. Levallois et al. Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. International Journal Of Infectious Diseases, 2012; 16 (1): e41–3.
Sczeto et al. Conservative management of polymicrobial peritonitis complicating peritoneal dialysis: a series of 140 consecutive cases. Am J Med. 2002; 113 (9):728-33.
Davenport A. Wellsted D. On behalf of the Pan Thames Renal Audit Peritoneal Dialysis Group. Does Antifungal Prophylaxis with Daily Oral Fluconazole Reduce the Risk of Fungal Peritonitis in Peritoneal Dialysis Patients? The Pan Thames Renal Audit. Blood Purif. 2011 ; 32:181–185.
Copyright (c) 2019 Moussokoro Hadja Kone, Tarik Bouattar, Ibtissam Fares, Meryem Benbella, Naima Ouzeddoun, Rabia Bayahia, Loubna Benamar
This work is licensed under a Creative Commons Attribution 4.0 International License.